Abiomed Inc. (NASDAQ:ABMD)

This company has been moved to the archive! The financial data has not been updated since November 3, 2022.

Statement of Comprehensive Income

Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.

Abiomed Inc., consolidated statement of comprehensive income

US$ in thousands

12 months ended:	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Net income	136,505)	225,525)	203,009)	259,016)	112,170)	52,116)
Foreign currency translation gains (losses)	(5,844)	2,142)	(1,832)	(11,431)	16,862)	(5,855)
Unrealized gains (losses) on derivative instrument	(1,779)	(2,095)	3,999)	—)	—)	—)
Net unrealized gains (losses) on marketable securities, net of tax	(8,092)	(303)	1,333)	946)	(460)	(211)
Other comprehensive income (loss)	(15,715)	(256)	3,500)	(10,485)	16,402)	(6,066)
Comprehensive income	120,790)	225,269)	206,509)	248,531)	128,572)	46,050)

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

Download chart